Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Borges

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Clinical Pharmacology and Therapeutics|November 1, 1984
Mesulergine, a new dopamine agonist: effects on anterior pituitary function and kineticsJ L Borges, H F Schran, W S Evans, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1984
Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal manM L Vance, J L Borges, D L Kaiser, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1985
Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal menW S Evans, M L Vance, D L Kaiser, et al.
Recent Progress in Hormone Research|January 1, 1986
Physiological and clinical studies of GRF and GHM O Thorner, M L Vance, W S Evans, et al.
Acta Neurochirurgica|January 1, 1985
Human pancreatic tumor GH-releasing factorM O Thorner, W S Evans, M Vance, et al.
Lancet (London, England)|January 1, 1983
Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in manM O Thorner, J Rivier, J Spiess, et al.
Lancet (London, England)|July 16, 1983
Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiencyJ L Borges, R M Blizzard, M C Gelato, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Clinical Pharmacology and Therapeutics|November 1, 1984
Mesulergine, a new dopamine agonist: effects on anterior pituitary function and kineticsJ L Borges, H F Schran, W S Evans, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1984
Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal manM L Vance, J L Borges, D L Kaiser, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1985
Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal menW S Evans, M L Vance, D L Kaiser, et al.
Recent Progress in Hormone Research|January 1, 1986
Physiological and clinical studies of GRF and GHM O Thorner, M L Vance, W S Evans, et al.
Acta Neurochirurgica|January 1, 1985
Human pancreatic tumor GH-releasing factorM O Thorner, W S Evans, M Vance, et al.
Lancet (London, England)|January 1, 1983
Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in manM O Thorner, J Rivier, J Spiess, et al.
Lancet (London, England)|July 16, 1983
Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiencyJ L Borges, R M Blizzard, M C Gelato, et al.
Pageof 4